Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

The ever-lengthening arm of p53.

Evan GI.

Cancer Cell. 2008 Aug 12;14(2):108-10. doi: 10.1016/j.ccr.2008.07.012.

2.

Too much of a good thing: the Prl-3 in p53's oyster.

Hinds PW.

Mol Cell. 2008 May 9;30(3):260-1. doi: 10.1016/j.molcel.2008.04.006.

3.

p53--a Jack of all trades but master of none.

Junttila MR, Evan GI.

Nat Rev Cancer. 2009 Nov;9(11):821-9. doi: 10.1038/nrc2728. Review.

PMID:
19776747
4.

Molecular architecture of tumor suppressor p53.

Viadiu H.

Curr Top Med Chem. 2008;8(15):1327-34. Review.

PMID:
18991721
5.

Wild-type p53 in cancer cells: when a guardian turns into a blackguard.

Kim E, Giese A, Deppert W.

Biochem Pharmacol. 2009 Jan 1;77(1):11-20. doi: 10.1016/j.bcp.2008.08.030. Review.

PMID:
18812169
6.

Ablation of key oncogenic pathways by RITA-reactivated p53 is required for efficient apoptosis.

Grinkevich VV, Nikulenkov F, Shi Y, Enge M, Bao W, Maljukova A, Gluch A, Kel A, Sangfelt O, Selivanova G.

Cancer Cell. 2009 May 5;15(5):441-53. doi: 10.1016/j.ccr.2009.03.021.

7.

p53 represses c-Myc through induction of the tumor suppressor miR-145.

Sachdeva M, Zhu S, Wu F, Wu H, Walia V, Kumar S, Elble R, Watabe K, Mo YY.

Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3207-12. doi: 10.1073/pnas.0808042106.

8.

Role for Kruppel-like factor 4 in determining the outcome of p53 response to DNA damage.

Zhou Q, Hong Y, Zhan Q, Shen Y, Liu Z.

Cancer Res. 2009 Nov 1;69(21):8284-92. doi: 10.1158/0008-5472.CAN-09-1345.

9.

CD44 keeps tumor killers polarized.

Mempel TR, Marangoni F.

Immunity. 2008 Dec 19;29(6):843-5. doi: 10.1016/j.immuni.2008.12.004.

10.

Cytotoxicity of natural extract from Tegillarca granosa on ovarian cancer cells is mediated by multiple molecules.

Gao MQ, Han YT, Zhu L, Chen SG, Hong ZY, Wang CB.

Clin Invest Med. 2009 Oct 1;32(5):E368-75.

PMID:
19796578
11.

Sirtuins and p53.

van Leeuwen I, Lain S.

Adv Cancer Res. 2009;102:171-95. doi: 10.1016/S0065-230X(09)02005-3. Review.

PMID:
19595309
12.

Peptide aptamers targeting mutant p53 induce apoptosis in tumor cells.

Guida E, Bisso A, Fenollar-Ferrer C, Napoli M, Anselmi C, Girardini JE, Carloni P, Del Sal G.

Cancer Res. 2008 Aug 15;68(16):6550-8. doi: 10.1158/0008-5472.CAN-08-0137.

13.

Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.

Bon G, Di Carlo SE, Folgiero V, Avetrani P, Lazzari C, D'Orazi G, Brizzi MF, Sacchi A, Soddu S, Blandino G, Mottolese M, Falcioni R.

Cancer Res. 2009 Jul 15;69(14):5978-86. doi: 10.1158/0008-5472.CAN-09-0244.

14.

The p53 tumor suppressor network in cancer and the therapeutic modulation of cell death.

Chari NS, Pinaire NL, Thorpe L, Medeiros LJ, Routbort MJ, McDonnell TJ.

Apoptosis. 2009 Apr;14(4):336-47. doi: 10.1007/s10495-009-0327-9. Review.

PMID:
19229632
15.

Simultaneous phosphorylation of p53 at serine 15 and 20 induces apoptosis in human glioma cells by increasing expression of pro-apoptotic genes.

Amano T, Nakamizo A, Mishra SK, Gumin J, Shinojima N, Sawaya R, Lang FF.

J Neurooncol. 2009 May;92(3):357-71. doi: 10.1007/s11060-009-9844-1.

PMID:
19357962
16.

p53: a new kingpin in the stem cell arena.

Aparicio S, Eaves CJ.

Cell. 2009 Sep 18;138(6):1060-2. doi: 10.1016/j.cell.2009.09.004.

17.

Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.

Suad O, Rozenberg H, Brosh R, Diskin-Posner Y, Kessler N, Shimon LJ, Frolow F, Liran A, Rotter V, Shakked Z.

J Mol Biol. 2009 Jan 9;385(1):249-65. doi: 10.1016/j.jmb.2008.10.063.

PMID:
18996393
18.

9-Aminoacridine-based anticancer drugs target the PI3K/AKT/mTOR, NF-kappaB and p53 pathways.

Guo C, Gasparian AV, Zhuang Z, Bosykh DA, Komar AA, Gudkov AV, Gurova KV.

Oncogene. 2009 Feb 26;28(8):1151-61. doi: 10.1038/onc.2008.460.

PMID:
19137016
19.

Expression of metallothionein and p53 antigens are correlated in oral squamous cell carcinoma.

Cardoso SV, Silveira-JĂșnior JB, De Carvalho Machado V, De-Paula AM, Loyola AM, De Aguiar MC.

Anticancer Res. 2009 Apr;29(4):1189-93.

20.

PH domain-only protein PHLDA3 is a p53-regulated repressor of Akt.

Kawase T, Ohki R, Shibata T, Tsutsumi S, Kamimura N, Inazawa J, Ohta T, Ichikawa H, Aburatani H, Tashiro F, Taya Y.

Cell. 2009 Feb 6;136(3):535-50. doi: 10.1016/j.cell.2008.12.002.

Items per page

Supplemental Content

Support Center